カテゴリー： QYResearch, 世界

世界のペプチド及びヘパリン市場 2019年

【英語タイトル】Global Peptides and Heparin Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X12781）・商品コード：DATA909X12781
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：113
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、ペプチド及びヘパリンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、インスリン、テリパラチド、リラグルチド、ロイプロリド、ロイプロリド、エクセナチド、カルシトニン、エナキサパリンナトリウム、ヘパリンナトリウムに、用途別には、糖尿病、感染症、がん、骨粗鬆症にセグメント区分し、ペプチド及びヘパリンの世界市場を分析しました。


・エグゼクティブ・サマリー
・ペプチド及びヘパリンの世界市場概要
・ペプチド及びヘパリンの製造コスト構成分析
・ペプチド及びヘパリンの開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・ペプチド及びヘパリンの地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・ペプチド及びヘパリンのセグメント分析（種類別）
（インスリン、テリパラチド、リラグルチド、ロイプロリド、ロイプロリド、エクセナチド、カルシトニン、エナキサパリンナトリウム、ヘパリンナトリウム）
・ペプチド及びヘパリンのセグメント分析（用途別）
（糖尿病、感染症、がん、骨粗鬆症）
・ペプチド及びヘパリンの主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Cipla Ltd.、Emcure Pharmaceuticals Pvt. Ltd.、Gland Pharma Limited、Troikaa Pharmaceuticals Ltd.、Biological E Limited、Bharat Biotech、Samarth Life Sciences Pvt. Ltd.、VHB Life Sciences Limited、Celon Laboratories Pvt. Ltd.、United Biotech (P) Limited、Biocon Limited、Sun Pharmaceutical Industries Ltd.、Wockhardt Ltd.、）
・ペプチド及びヘパリンの市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Peptides and Heparin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Peptides and Heparin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Peptides and Heparin market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Peptides and Heparin in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Peptides and Heparin manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Cipla Ltd.
Emcure Pharmaceuticals Pvt. Ltd.
Gland Pharma Limited
Troikaa Pharmaceuticals Ltd.
Biological E Limited
Bharat Biotech
Samarth Life Sciences Pvt. Ltd.
VHB Life Sciences Limited
Celon Laboratories Pvt. Ltd.
United Biotech (P) Limited
Biocon Limited
Sun Pharmaceutical Industries Ltd.
Wockhardt Ltd.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Insulin
Teriparatide
Liraglutide
Leuprolide
Leuprolide
Exenatide
Calcitonin
Enaxaparin Sodium
Heparin Sodium

Segment by Application
Diabetes
Infectious Diseases
Cancer
Osteoporosis

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Peptides and Heparin
1.1 Definition of Peptides and Heparin
1.2 Peptides and Heparin Segment by Type
1.2.1 Global Peptides and Heparin Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Insulin
1.2.3 Teriparatide
1.2.4 Liraglutide
1.2.5 Leuprolide
1.2.6 Leuprolide
1.2.7 Exenatide
1.2.8 Calcitonin
1.2.9 Enaxaparin Sodium
1.2.10 Heparin Sodium
1.3 Peptides and Heparin Segment by Applications
1.3.1 Global Peptides and Heparin Consumption Comparison by Applications (2014-2025)
1.3.2 Diabetes
1.3.3 Infectious Diseases
1.3.4 Cancer
1.3.5 Osteoporosis
1.4 Global Peptides and Heparin Overall Market
1.4.1 Global Peptides and Heparin Revenue (2014-2025)
1.4.2 Global Peptides and Heparin Production (2014-2025)
1.4.3 North America Peptides and Heparin Status and Prospect (2014-2025)
1.4.4 Europe Peptides and Heparin Status and Prospect (2014-2025)
1.4.5 China Peptides and Heparin Status and Prospect (2014-2025)
1.4.6 Japan Peptides and Heparin Status and Prospect (2014-2025)
1.4.7 Southeast Asia Peptides and Heparin Status and Prospect (2014-2025)
1.4.8 India Peptides and Heparin Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Peptides and Heparin
2.3 Manufacturing Process Analysis of Peptides and Heparin
2.4 Industry Chain Structure of Peptides and Heparin

3 Development and Manufacturing Plants Analysis of Peptides and Heparin
3.1 Capacity and Commercial Production Date
3.2 Global Peptides and Heparin Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Peptides and Heparin
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Peptides and Heparin Production and Capacity Analysis
4.2 Peptides and Heparin Revenue Analysis
4.3 Peptides and Heparin Price Analysis
4.4 Market Concentration Degree

5 Peptides and Heparin Regional Market Analysis
5.1 Peptides and Heparin Production by Regions
5.1.1 Global Peptides and Heparin Production by Regions
5.1.2 Global Peptides and Heparin Revenue by Regions
5.2 Peptides and Heparin Consumption by Regions
5.3 North America Peptides and Heparin Market Analysis
5.3.1 North America Peptides and Heparin Production
5.3.2 North America Peptides and Heparin Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Peptides and Heparin Import and Export
5.4 Europe Peptides and Heparin Market Analysis
5.4.1 Europe Peptides and Heparin Production
5.4.2 Europe Peptides and Heparin Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Peptides and Heparin Import and Export
5.5 China Peptides and Heparin Market Analysis
5.5.1 China Peptides and Heparin Production
5.5.2 China Peptides and Heparin Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Peptides and Heparin Import and Export
5.6 Japan Peptides and Heparin Market Analysis
5.6.1 Japan Peptides and Heparin Production
5.6.2 Japan Peptides and Heparin Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Peptides and Heparin Import and Export
5.7 Southeast Asia Peptides and Heparin Market Analysis
5.7.1 Southeast Asia Peptides and Heparin Production
5.7.2 Southeast Asia Peptides and Heparin Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Peptides and Heparin Import and Export
5.8 India Peptides and Heparin Market Analysis
5.8.1 India Peptides and Heparin Production
5.8.2 India Peptides and Heparin Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Peptides and Heparin Import and Export

6 Peptides and Heparin Segment Market Analysis (by Type)
6.1 Global Peptides and Heparin Production by Type
6.2 Global Peptides and Heparin Revenue by Type
6.3 Peptides and Heparin Price by Type

7 Peptides and Heparin Segment Market Analysis (by Application)
7.1 Global Peptides and Heparin Consumption by Application
7.2 Global Peptides and Heparin Consumption Market Share by Application (2014-2019)

8 Peptides and Heparin Major Manufacturers Analysis
8.1 Cipla Ltd.
8.1.1 Cipla Ltd. Peptides and Heparin Production Sites and Area Served
8.1.2 Cipla Ltd. Product Introduction, Application and Specification
8.1.3 Cipla Ltd. Peptides and Heparin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Emcure Pharmaceuticals Pvt. Ltd.
8.2.1 Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Production Sites and Area Served
8.2.2 Emcure Pharmaceuticals Pvt. Ltd. Product Introduction, Application and Specification
8.2.3 Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Gland Pharma Limited
8.3.1 Gland Pharma Limited Peptides and Heparin Production Sites and Area Served
8.3.2 Gland Pharma Limited Product Introduction, Application and Specification
8.3.3 Gland Pharma Limited Peptides and Heparin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Troikaa Pharmaceuticals Ltd.
8.4.1 Troikaa Pharmaceuticals Ltd. Peptides and Heparin Production Sites and Area Served
8.4.2 Troikaa Pharmaceuticals Ltd. Product Introduction, Application and Specification
8.4.3 Troikaa Pharmaceuticals Ltd. Peptides and Heparin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Biological E Limited
8.5.1 Biological E Limited Peptides and Heparin Production Sites and Area Served
8.5.2 Biological E Limited Product Introduction, Application and Specification
8.5.3 Biological E Limited Peptides and Heparin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Bharat Biotech
8.6.1 Bharat Biotech Peptides and Heparin Production Sites and Area Served
8.6.2 Bharat Biotech Product Introduction, Application and Specification
8.6.3 Bharat Biotech Peptides and Heparin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Samarth Life Sciences Pvt. Ltd.
8.7.1 Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Production Sites and Area Served
8.7.2 Samarth Life Sciences Pvt. Ltd. Product Introduction, Application and Specification
8.7.3 Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 VHB Life Sciences Limited
8.8.1 VHB Life Sciences Limited Peptides and Heparin Production Sites and Area Served
8.8.2 VHB Life Sciences Limited Product Introduction, Application and Specification
8.8.3 VHB Life Sciences Limited Peptides and Heparin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Celon Laboratories Pvt. Ltd.
8.9.1 Celon Laboratories Pvt. Ltd. Peptides and Heparin Production Sites and Area Served
8.9.2 Celon Laboratories Pvt. Ltd. Product Introduction, Application and Specification
8.9.3 Celon Laboratories Pvt. Ltd. Peptides and Heparin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 United Biotech (P) Limited
8.10.1 United Biotech (P) Limited Peptides and Heparin Production Sites and Area Served
8.10.2 United Biotech (P) Limited Product Introduction, Application and Specification
8.10.3 United Biotech (P) Limited Peptides and Heparin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Biocon Limited
8.12 Sun Pharmaceutical Industries Ltd.
8.13 Wockhardt Ltd.

9 Development Trend of Analysis of Peptides and Heparin Market
9.1 Global Peptides and Heparin Market Trend Analysis
9.1.1 Global Peptides and Heparin Market Size (Volume and Value) Forecast 2019-2025
9.2 Peptides and Heparin Regional Market Trend
9.2.1 North America Peptides and Heparin Forecast 2019-2025
9.2.2 Europe Peptides and Heparin Forecast 2019-2025
9.2.3 China Peptides and Heparin Forecast 2019-2025
9.2.4 Japan Peptides and Heparin Forecast 2019-2025
9.2.5 Southeast Asia Peptides and Heparin Forecast 2019-2025
9.2.6 India Peptides and Heparin Forecast 2019-2025
9.3 Peptides and Heparin Market Trend (Product Type)
9.4 Peptides and Heparin Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Peptides and Heparin Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Peptides and Heparin
Table Global Peptides and Heparin Production (K MT) Growth Rate Comparison by Types (2014-2025)
Figure Global Peptides and Heparin Production Market Share by Types in 2018
Figure Insulin Product Picture
Figure Teriparatide Product Picture
Figure Liraglutide Product Picture
Figure Leuprolide Product Picture
Figure Leuprolide Product Picture
Figure Exenatide Product Picture
Figure Calcitonin Product Picture
Figure Enaxaparin Sodium Product Picture
Figure Heparin Sodium Product Picture
Table Global Peptides and Heparin Consumption (K MT) Comparison by Applications (2014-2025)
Figure Global Peptides and Heparin Consumption Market Share by Applications in 2018
Figure Diabetes
Figure Infectious Diseases
Figure Cancer
Figure Osteoporosis
Figure Global Peptides and Heparin Revenue (Million USD) (2014-2025)
Figure Global Peptides and Heparin Production (K MT) (2014-2025)
Figure North America Peptides and Heparin Market Size (Million USD) (2014-2025)
Figure Europe Peptides and Heparin Market Size (Million USD) (2014-2025)
Figure China Peptides and Heparin Market Size (Million USD) (2014-2025)
Figure Japan Peptides and Heparin Market Size (Million USD) (2014-2025)
Figure Southeast Asia Peptides and Heparin Market Size (Million USD) (2014-2025)
Figure India Peptides and Heparin Market Size (Million USD) (2014-2025)
Table Peptides and Heparin Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Peptides and Heparin in 2018
Figure Manufacturing Process Analysis of Peptides and Heparin
Figure Industry Chain Structure of Peptides and Heparin
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Peptides and Heparin Manufacturing Plants Distribution
Table Peptides and Heparin Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Peptides and Heparin Capacity (K MT) of Major Manufacturers (2014-2019)
Table Peptides and Heparin Production (K MT) of Major Manufacturers (2014-2019)
Table Peptides and Heparin Production Market Share of Major Manufacturers (2014-2019)
Figure Peptides and Heparin Production Share by Manufacturers in 2018
Table Peptides and Heparin Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Peptides and Heparin Revenue Market Share of Major Manufacturers (2014-2019)
Figure Peptides and Heparin Revenue Share by Manufacturers in 2018
Table Peptides and Heparin Average Price (USD/MT) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Peptides and Heparin Production by Regions 2014-2019 (K MT)
Table Global Peptides and Heparin Production Market Share by Regions 2014-2019
Figure Global Peptides and Heparin Production Market Share by Regions in 2018
Table Global Peptides and Heparin Revenue by Regions 2014-2019 (Million USD)
Table Global Peptides and Heparin Revenue Market Share by Regions 2014-2019
Figure Global Peptides and Heparin Revenue Market Share by Regions in 2018
Table Global Peptides and Heparin Consumption by Regions 2014-2019 (K MT)
Table Global Peptides and Heparin Consumption Market Share by Regions 2014-2019
Figure North America Peptides and Heparin Production Growth Rate 2014-2019 (K MT)
Figure North America Peptides and Heparin Revenue Growth Rate 2014-2019 (Million USD)
Table North America Peptides and Heparin Production, Consumption Import and Export (K MT)
Figure Europe Peptides and Heparin Production Growth Rate 2014-2019 (K MT)
Figure Europe Peptides and Heparin Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Peptides and Heparin Production, Consumption Import and Export (K MT)
Figure China Peptides and Heparin Production Growth Rate 2014-2019 (K MT)
Figure China Peptides and Heparin Revenue Growth Rate 2014-2019 (Million USD)
Table China Peptides and Heparin Production, Consumption Import and Export (K MT)
Figure Japan Peptides and Heparin Production Growth Rate 2014-2019 (K MT)
Figure Japan Peptides and Heparin Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Peptides and Heparin Production, Consumption Import and Export (K MT)
Figure Southeast Asia Peptides and Heparin Production Growth Rate 2014-2019 (K MT)
Figure Southeast Asia Peptides and Heparin Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Peptides and Heparin Production, Consumption Import and Export (K MT)
Figure India Peptides and Heparin Production Growth Rate 2014-2019 (K MT)
Figure India Peptides and Heparin Revenue Growth Rate 2014-2019 (Million USD)
Table India Peptides and Heparin Production, Consumption Import and Export (K MT)
Figure Global Consumption Peptides and Heparin Market Share by Application (2014-2019)
Figure Global Value (Consumption) Peptides and Heparin Market Share by Application (2014-2019)
Table Cipla Ltd. Peptides and Heparin Production Sites and Area Served
Table Cipla Ltd. Peptides and Heparin Product Introduction, Application and Specification
Table Cipla Ltd. Peptides and Heparin Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Cipla Ltd. Peptides and Heparin Production Growth Rate (2014-2019)
Table Cipla Ltd. Peptides and Heparin Production Market Share (2014-2019)
Figure Cipla Ltd. Peptides and Heparin Revenue Market Share (2014-2019)
Table Cipla Ltd. Peptides and Heparin Main Business and Markets Served
Table Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Production Sites and Area Served
Table Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Product Introduction, Application and Specification
Table Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Production Growth Rate (2014-2019)
Table Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Production Market Share (2014-2019)
Figure Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Revenue Market Share (2014-2019)
Table Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Main Business and Markets Served
Table Gland Pharma Limited Peptides and Heparin Production Sites and Area Served
Table Gland Pharma Limited Peptides and Heparin Product Introduction, Application and Specification
Table Gland Pharma Limited Peptides and Heparin Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Gland Pharma Limited Peptides and Heparin Production Growth Rate (2014-2019)
Table Gland Pharma Limited Peptides and Heparin Production Market Share (2014-2019)
Figure Gland Pharma Limited Peptides and Heparin Revenue Market Share (2014-2019)
Table Gland Pharma Limited Peptides and Heparin Main Business and Markets Served
Table Troikaa Pharmaceuticals Ltd. Peptides and Heparin Production Sites and Area Served
Table Troikaa Pharmaceuticals Ltd. Peptides and Heparin Product Introduction, Application and Specification
Table Troikaa Pharmaceuticals Ltd. Peptides and Heparin Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Troikaa Pharmaceuticals Ltd. Peptides and Heparin Production Growth Rate (2014-2019)
Table Troikaa Pharmaceuticals Ltd. Peptides and Heparin Production Market Share (2014-2019)
Figure Troikaa Pharmaceuticals Ltd. Peptides and Heparin Revenue Market Share (2014-2019)
Table Troikaa Pharmaceuticals Ltd. Peptides and Heparin Main Business and Markets Served
Table Biological E Limited Peptides and Heparin Production Sites and Area Served
Table Biological E Limited Peptides and Heparin Product Introduction, Application and Specification
Table Biological E Limited Peptides and Heparin Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Biological E Limited Peptides and Heparin Production Growth Rate (2014-2019)
Table Biological E Limited Peptides and Heparin Production Market Share (2014-2019)
Figure Biological E Limited Peptides and Heparin Revenue Market Share (2014-2019)
Table Biological E Limited Peptides and Heparin Main Business and Markets Served
Table Bharat Biotech Peptides and Heparin Production Sites and Area Served
Table Bharat Biotech Peptides and Heparin Product Introduction, Application and Specification
Table Bharat Biotech Peptides and Heparin Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Bharat Biotech Peptides and Heparin Production Growth Rate (2014-2019)
Table Bharat Biotech Peptides and Heparin Production Market Share (2014-2019)
Figure Bharat Biotech Peptides and Heparin Revenue Market Share (2014-2019)
Table Bharat Biotech Peptides and Heparin Main Business and Markets Served
Table Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Production Sites and Area Served
Table Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Product Introduction, Application and Specification
Table Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Production Growth Rate (2014-2019)
Table Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Production Market Share (2014-2019)
Figure Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Revenue Market Share (2014-2019)
Table Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Main Business and Markets Served
Table VHB Life Sciences Limited Peptides and Heparin Production Sites and Area Served
Table VHB Life Sciences Limited Peptides and Heparin Product Introduction, Application and Specification
Table VHB Life Sciences Limited Peptides and Heparin Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table VHB Life Sciences Limited Peptides and Heparin Production Growth Rate (2014-2019)
Table VHB Life Sciences Limited Peptides and Heparin Production Market Share (2014-2019)
Figure VHB Life Sciences Limited Peptides and Heparin Revenue Market Share (2014-2019)
Table VHB Life Sciences Limited Peptides and Heparin Main Business and Markets Served
Table Celon Laboratories Pvt. Ltd. Peptides and Heparin Production Sites and Area Served
Table Celon Laboratories Pvt. Ltd. Peptides and Heparin Product Introduction, Application and Specification
Table Celon Laboratories Pvt. Ltd. Peptides and Heparin Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Celon Laboratories Pvt. Ltd. Peptides and Heparin Production Growth Rate (2014-2019)
Table Celon Laboratories Pvt. Ltd. Peptides and Heparin Production Market Share (2014-2019)
Figure Celon Laboratories Pvt. Ltd. Peptides and Heparin Revenue Market Share (2014-2019)
Table Celon Laboratories Pvt. Ltd. Peptides and Heparin Main Business and Markets Served
Table United Biotech (P) Limited Peptides and Heparin Production Sites and Area Served
Table United Biotech (P) Limited Peptides and Heparin Product Introduction, Application and Specification
Table United Biotech (P) Limited Peptides and Heparin Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table United Biotech (P) Limited Peptides and Heparin Production Growth Rate (2014-2019)
Table United Biotech (P) Limited Peptides and Heparin Production Market Share (2014-2019)
Figure United Biotech (P) Limited Peptides and Heparin Revenue Market Share (2014-2019)
Table United Biotech (P) Limited Peptides and Heparin Main Business and Markets Served
Table Biocon Limited Peptides and Heparin Production Sites and Area Served
Table Sun Pharmaceutical Industries Ltd. Peptides and Heparin Production Sites and Area Served
Table Wockhardt Ltd. Peptides and Heparin Production Sites and Area Served
Figure Global Peptides and Heparin Production (K MT) Growth Rate Forecast 2019-2025
Figure Global Peptides and Heparin Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Peptides and Heparin Sales Price (USD/MT) Forecast 2019-2025
Figure North America Peptides and Heparin Production Growth Rate Forecast 2019-2025 (K MT)
Figure North America Peptides and Heparin Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Peptides and Heparin Production Growth Rate Forecast 2019-2025 (K MT)
Figure Europe Peptides and Heparin Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Peptides and Heparin Production Growth Rate Forecast 2019-2025 (K MT)
Figure China Peptides and Heparin Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Peptides and Heparin Production Growth Rate Forecast 2019-2025 (K MT)
Figure Japan Peptides and Heparin Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Peptides and Heparin Production Growth Rate Forecast 2019-2025 (K MT)
Figure Southeast Asia Peptides and Heparin Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Peptides and Heparin Production Growth Rate Forecast 2019-2025 (K MT)
Figure India Peptides and Heparin Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K MT) of Peptides and Heparin by Type (2019-2025)
Table Global Consumption (K MT) of Peptides and Heparin by Application (2019-2025)
Table Peptides and Heparin Distributors List
Table Peptides and Heparin Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Cipla Ltd.、Emcure Pharmaceuticals Pvt. Ltd.、Gland Pharma Limited、Troikaa Pharmaceuticals Ltd.、Biological E Limited、Bharat Biotech、Samarth Life Sciences Pvt. Ltd.、VHB Life Sciences Limited、Celon Laboratories Pvt. Ltd.、United Biotech (P) Limited、Biocon Limited、Sun Pharmaceutical Industries Ltd.、Wockhardt Ltd.、

★調査レポート[世界のペプチド及びヘパリン市場 2019年] (コード：DATA909X12781)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のペプチド及びヘパリン市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のヘパリン（ヘパリンナトリウム及びヘパリンカルシウム）市場 2019年
    DATA909X08953 / QYResearch / 2019年11月20日 / ※本調査レポートは、ヘパリン（ヘパリンナトリウム及びヘパリンカルシウム）の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ヘパリンナトリウム、ヘパリンカルシウムに、用途別には、未分画ヘパリン、低分子ヘパリンAPIにセグメント区分し、ヘパリン（ヘパリンナトリウム及びヘパリンカルシウム）の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ヘパリン（ヘパリンナトリウム及びヘパリンカルシウム）の世界市場概要 ・ヘパリン（ヘパリンナトリウム及びヘパリンカルシウム）の製造コスト構成分析 ・ヘパリン（ヘパリンナトリウム及びヘパリンカルシウム）の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ヘパリン（ヘパリンナトリウム及びヘパリンカルシウム）の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ヘパリン（ヘパリンナトリウム及びヘパリンカルシウム）のセグメント分析（種類別） （ヘパリンナトリウム、ヘパリンカルシウム）...The global Heparin(Heparin Sodium and Heparin Calcium) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Heparin(Heparin Sodium and Heparin Calcium) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Heparin(Heparin Sodium and Heparin Calcium) market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Heparin(Heparin Sodium and Heparin Calcium) in North America, Europe, China, Japan, Southeast Asia and...
  • 世界のペプチド市場 2019年
    DATA909X12782 / QYResearch / 2019年11月20日 / ※本調査レポートは、ペプチドの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、インスリン、テリパラチド、リラグルチド、ロイプロリドに、用途別には、糖尿病、感染症、がん、骨粗鬆症にセグメント区分し、ペプチドの世界市場を分析しました。 ・エグゼクティブ・サマリー ・ペプチドの世界市場概要 ・ペプチドの製造コスト構成分析 ・ペプチドの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ペプチドの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ペプチドのセグメント分析（種類別） （インスリン、テリパラチド、リラグルチド、ロイプロリド）...The global Peptides market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Peptides volume and value at global level, regional level and company level. From a global perspective, this report represents overall Peptides market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Peptides in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Peptides manufacturing sites, capacity, production, ex-factory price,...
  • 世界の未分画ヘパリン市場 2019年
    DATA909X17116 / QYResearch / 2019年11月22日 / ※本調査レポートは、未分画ヘパリンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ウシ、ブタに、用途別には、病院、クリニック、その他にセグメント区分し、未分画ヘパリンの世界市場を分析しました。 ・エグゼクティブ・サマリー ・未分画ヘパリンの世界市場概要 ・未分画ヘパリンの製造コスト構成分析 ・未分画ヘパリンの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・未分画ヘパリンの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・未分画ヘパリンのセグメント分析（種類別） （ウシ、ブタ）...The global Unfractionated Heparin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Unfractionated Heparin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Unfractionated Heparin market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Unfractionated Heparin in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Unfractionated Heparin manufacturing...
  • 世界のヘパリン有効成分市場 2019年
    DATA909X08952 / QYResearch / 2019年11月20日 / ※本調査レポートは、ヘパリン有効成分の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ヘパリンナトリウム、ヘパリンカルシウム、その他に、用途別には、UFH、LMWHにセグメント区分し、ヘパリン有効成分の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ヘパリン有効成分の世界市場概要 ・ヘパリン有効成分の製造コスト構成分析 ・ヘパリン有効成分の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ヘパリン有効成分の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ヘパリン有効成分のセグメント分析（種類別） （ヘパリンナトリウム、ヘパリンカルシウム、その他）...The global Heparin Active Pharmaceutical Ingredients market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Heparin Active Pharmaceutical Ingredients volume and value at global level, regional level and company level. From a global perspective, this report represents overall Heparin Active Pharmaceutical Ingredients market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Heparin Active Pharmaceutical Ingredients in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の超低分子量ヘパリン(ULMWH) 市場 2019年
    DATA909X17033 / QYResearch / 2019年11月22日 / ※本調査レポートは、超低分子量ヘパリン(ULMWH) の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ウシ、ブタに、用途別には、静脈血栓塞栓症治療、妊娠合併症、心房細動/粗動カーディオバージョンにセグメント区分し、超低分子量ヘパリン(ULMWH) の世界市場を分析しました。 ・エグゼクティブ・サマリー ・超低分子量ヘパリン(ULMWH) の世界市場概要 ・超低分子量ヘパリン(ULMWH) の製造コスト構成分析 ・超低分子量ヘパリン(ULMWH) の開発・製造工場分析...The global Ultra-low Molecular Weight Heparin (ULMWH) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Ultra-low Molecular Weight Heparin (ULMWH) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ultra-low Molecular Weight Heparin (ULMWH) market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Ultra-low Molecular Weight Heparin (ULMWH) in North America, Europe, China, Japan, Southeast Asia and...
  • 世界のヘパリン（低分子量）市場 2019年
    DATA909X08951 / QYResearch / 2019年11月20日 / ※本調査レポートは、ヘパリン（低分子量）の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エノキサパリン、ダルテパリン、チンザパリン、フラキシパリンに、用途別には、静脈血栓塞栓症治療、妊娠合併症、心房細動/フラッター電気的除細動、その他にセグメント区分し、ヘパリン（低分子量）の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ヘパリン（低分子量）の世界市場概要 ・ヘパリン（低分子量）の製造コスト構成分析 ・ヘパリン（低分子量）の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ヘパリン（低分子量）の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ヘパリン（低分子量）のセグメント分析（種類別） （エノキサパリン、ダルテパリン、チンザパリン、フラキシパリン）...The global Heparin (Low Molecular Weight) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Heparin (Low Molecular Weight) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Heparin (Low Molecular Weight) market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Heparin (Low Molecular Weight) in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の抗菌ペプチド市場 2019年
    DATA909X03657 / QYResearch / 2019年11月15日 / ※本調査レポートは、抗菌ペプチドの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、植物抗菌ペプチド、細菌抗菌ペプチド、動物抗菌ペプチド、昆虫抗菌ペプチドに、用途別には、製薬＆ヘルスケア、農業、生物工学にセグメント区分し、抗菌ペプチドの世界市場を分析しました。 ・エグゼクティブ・サマリー ・抗菌ペプチドの世界市場概要 ・抗菌ペプチドの製造コスト構成分析 ・抗菌ペプチドの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・抗菌ペプチドの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・抗菌ペプチドのセグメント分析（種類別） （植物抗菌ペプチド、細菌抗菌ペプチド、動物抗菌ペプチド、昆虫抗菌ペプチド）...The global Antimicrobial Peptides market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Antimicrobial Peptides volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antimicrobial Peptides market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Antimicrobial Peptides in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Antimicrobial Peptides manufacturing...
  • 世界の低分子量ヘパリン（LMWH）市場 2019年
    DATA909X10731 / QYResearch / 2019年11月20日 / ※本調査レポートは、低分子量ヘパリン（LMWH）の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エノキサパリン、ダルテパリン、チンザパリン、フラキシパリンに、用途別には、静脈血栓塞栓症治療、妊娠合併症、心房細動/フラッター電気的除細動、その他にセグメント区分し、低分子量ヘパリン（LMWH）の世界市場を分析しました。 ・エグゼクティブ・サマリー ・低分子量ヘパリン（LMWH）の世界市場概要 ・低分子量ヘパリン（LMWH）の製造コスト構成分析 ・低分子量ヘパリン（LMWH）の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・低分子量ヘパリン（LMWH）の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・低分子量ヘパリン（LMWH）のセグメント分析（種類別） （エノキサパリン、ダルテパリン、チンザパリン、フラキシパリン）...The global Low Molecular Weight Heparin (LMWHs) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Low Molecular Weight Heparin (LMWHs) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Low Molecular Weight Heparin (LMWHs) market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Low Molecular Weight Heparin (LMWHs) in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の低分子量ヘパリンナトリウム市場 2019年
    DATA909X10732 / QYResearch / 2019年11月20日 / ※本調査レポートは、低分子量ヘパリンナトリウムの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エノキサパリン、ダルテパリン、チンザパリン、フラキシパリンに、用途別には、医療、研究にセグメント区分し、低分子量ヘパリンナトリウムの世界市場を分析しました。 ・エグゼクティブ・サマリー ・低分子量ヘパリンナトリウムの世界市場概要 ・低分子量ヘパリンナトリウムの製造コスト構成分析 ・低分子量ヘパリンナトリウムの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・低分子量ヘパリンナトリウムの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・低分子量ヘパリンナトリウムのセグメント分析（種類別） （エノキサパリン、ダルテパリン、チンザパリン、フラキシパリン）...The global Low Molecular Weight Heparin Sodium market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Low Molecular Weight Heparin Sodium volume and value at global level, regional level and company level. From a global perspective, this report represents overall Low Molecular Weight Heparin Sodium market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Low Molecular Weight Heparin Sodium in North America, Europe, China, Japan, Southeast Asia and...

    • ◆H&Iグローバルリサーチのお客様（例）◆